chylomicrons, low-density lipoproteins (LDLs), and verylow-density lipoproteins (VLDL), modulate angiogenesis by regulating the expression of the endothelial decoy receptor VEGFR1. 10 Zebrafish stalactite (stl) mutants, which carry a mutation in the microsomal triglyceride transfer protein (mtp) gene 11 and are consequently devoid of ApoB lipoproteins, display excessive sprouting angiogenesis because of downregulation of VEGF receptor 1 (vegfr1) levels. 10 In contrast, ablation of apoCII expression induced pronounced hyperlipidemia 10, 12 with concomitant upregulation of Vegfr1 and severely impaired angiogenesis. ApoCII is a coactivator of lipoprotein lipase, which is required for the hydrolysis and release of fatty acids from ApoB lipoproteins to the tissue. 13 Zebrafish apoCII mutants recapitulate the hyperlipidemic phenotype induced by the antisense morpholino oligonucleotide (MO) and display defects in angiogenesis, although less severe. 12 Interestingly, in these mutants, the vascular phenotypes recover by ≈14 days post fertilization (dpf), suggesting specific roles for lipoproteins during embryonic development that are later on compensated for by other mechanisms. This notion is in line with the fact that hyperlipidemic mice and humans generally survive to adulthood with no major vascular defects, although they are at increased risk of developing endothelial dysfunction, cardiovascular disease, and premature death. 14, 15 Although the strong link between circulating lipoproteins and EC behavior is becoming evident, the molecular mechanisms underlying this interaction have remained unclear. In this work, we used a global expression profiling approach to identify EC-specific factors mediating the response of the endothelium to lipoprotein levels in vivo. We identify the secreted enzyme Autotaxin, also known as ectonucleotide pyrophosphatase/ phosphodiesterase 2 (Enpp2), as a downstream target of ApoB lipoproteins in ECs. We further demonstrate that Autotaxin modulates different aspects of EC behavior through the generation of the bioactive, lipid-signaling molecule lysophosphatidic acid (LPA), and activation of EC-specific LPA receptors. Our results uncover a novel signaling circuit activated in ECs in response to lipoprotein availability and open new avenues of research into endothelial dysfunction associated with hyperlipidemia.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
To characterize the molecular mechanisms underlying the effects of lipoproteins on angiogenesis in vivo, we performed microarray analysis on zebrafish ECs facing different levels of ApoB lipoproteins. To this end, we isolated fli:EGFP + ECs by fluorescence-activated cell sorting (FACS) 16 from 3 dpf wildtype (WT), stl mutants-, which are devoid of ApoB lipoproteins, and hyperlipidemic apoCII MO-injected embryos ( Figure 1A ; Figure IA and IB in the online-only Data Supplement). After sorting, RNA was extracted and hybridized to an Agilent 4×44 microarray. The data were analyzed to compare between the outcomes of (1) high and normal lipoprotein levels (apoCII versus WT), (2) low and normal lipoprotein levels (stl versus WT), and (3) high and low lipoprotein levels (apoCII versus stl). We found a large number of genes whose expression changed specifically in either stl-or apoCII MO-derived ECs, as compared with the WT sample ( Figure 1B ; Tables I and II in the online-only Data Supplement), suggesting that different levels of ApoB lipoproteins result in activation of distinct gene sets within ECs. We also found that hyperlipidemia induced a more pronounced transcriptional response than lipoprotein depletion, as manifested by the larger number of genes with differential expression levels detected in apoCII morphant-, as compared with stl-derived ECs ( Figure 1B ; Tables I and II in the online-only Data Supplement).
We used gene ontology annotations to assign biological processes and molecular functions to genes that changed significantly only in hypo-or hyperlipidemia (Tables I and  II in the online-only Data Supplement) or in both conditions, either in opposite ( Table III in the online-only Data Supplement) or correlative manner ( Table IV in the onlineonly Data Supplement). We found that the large majority of the genes showing specific differential expression in stlderived ECs were related to metabolic pathways and to energy production networks (Figure IIA and IIA′ and Table V in the online-only Data Supplement). Specifically, a significant difference was detected in the expression of genes involved in amino acid metabolism, which could potentially be linked to enhanced proliferation detected of stl ECs. Interestingly, in apoCII MO-derived ECs, a large percentage of differentially expressed genes was related to signaling pathways that regulate angiogenesis, such as MAPK (mitogen-activated protein kinase), Delta-Notch, and Wnt [17] [18] [19] ( Figure IIB and IIB′ in the online-only Data Supplement), highlighting the important role of lipoproteins as signaling mediators, besides their serving as carriers of cholesterol and triglycerides. 20 In addition, around 9% of the genes whose expression changed specifically in apoCII ECs were related to apoptosis, reflecting the deleterious effects of high lipoprotein levels on the endothelium.
We have previously demonstrated that in both stl mutants and apoCII morphants, lipoproteins do not reach the end tissues, rendering embryos under severe fatty acid starvation. 10 We hypothesized that a response to this global starvation should be reflected by correlative changes in gene expression in apoCII morphants and stl mutant--derived ECs. Surprisingly however, metabolic-, and stress-related genes represented only a small fraction of the correlative gene classification ( Figure 1C ; Figure IIC in the online-only Data Supplement), further supporting the notion that lipoproteins activate specific pathways within ECs, rather than inducing a generalized stress response. In contrast, we detected significant correlative changes in focal adhesion genes, which could likely account for alterations in Conversely, in apoCII morphants, hyperlipidemia causes severe defects in the formation of the trunk vasculature. fli:EGFP + ECs were isolated by fluorescence-activated cell sorting (FACS), followed by RNA extraction and hybridization to a zebrafish microarray. B, Dot plot of genes whose expression changed specifically and significantly in either stl vs WT or apoCII vs. WT. Green: downregulated genes, red: upregulated genes, and gray: nonsignificant. X axis: probe ID number. Significant up-or downregulation >3-fold change. C, Bar graph of genes that showed correlative changes in stl vs WT and apoCII vs WT but showed no significant changes in apoCII vs stl. D, Bar graph of genes that showed opposite changes in stl vs WT and apoCII vs WT, accompanied by a EC migration in stl mutants, or in vessel instability in apoCII morphants as both processes involve EC detachment from the surrounding extracellular matrix. 21 We next analyzed genes whose expression changed in opposite directions when comparing apoCII morphants and stl mutants, that is, genes that are upregulated in one model and downregulated in the other and vice versa. Because we reasoned that a specific response of ECs to contrasting levels of plasma lipoproteins would be reflected by these alterations, we focused our studies on this set of genes ( Figure 1D ; Figure IID in the online-only Data Supplement). In this context, we found that expression of enpp2/atx was upregulated in stl mutant-and downregulated in apoCII morphant-derived ECs ( Figure 1E and 1F ). AUTOTAXIN is a secreted enzyme found to be expressed by a large variety of tumor cells including, among others, melanoma, breast cancer, and glioblastoma. 22 AUTOTAXIN was shown to act as a prometastatic 23 and proangiogenic factor in a Matrigel plug assay 24 and to promote vessel stabilization in an allantois explant culture system. 25 Nonetheless, the study of its regulation during embryonic development, as well as of its tissue sources in normal physiology, has been hampered by the lack of suitable in vivo models. Autotaxin knockout mice die at embryonic day 9.5 because of profound vascular defects, both in the embryo and in the yolk sac. 25, 26 In zebrafish, Autotaxin has been shown to be involved in the establishment of left-right asymmetry, 27 in oligodendrocyte differentiation, 28 and in formation of the vascular system. 29, 30 Specifically, MO-mediated knockdown of atx in zebrafish embryos induced defects in intersegmental vessel formation. 29 However, the molecular mechanisms regulating its expression and mode of action have remained unclear. To investigate the putative role of Autotaxin in the EC response to lipoprotein levels, we first assessed its expression pattern in zebrafish embryos using in situ hybridization. At 24 hours post fertilization (hpf), clear staining was detected in the main axial vessels ( Figure 1G ). In addition, quantitative real-time polymerase chain reaction (qRT-PCR) comparing FACS-sorted fli:EGFP + ECs versus fli:EGFP − non-ECs showed enhanced atx expression in the EC fraction ( Figure 1H ).
The fact that atx expression was upregulated in stl mutants, which exhibit excessive sprouting angiogenesis in response to lipoprotein deficiency (Figure 2A through 2D) , 10 prompted us to investigate whether autotaxin contributes to this phenotype. Injection of atx mRNA into one-cell stage zebrafish embryos resulted in the presence of ectopic SIV (subintestinal vessel) sprouts (Figure 2E , 2G, and 2H) reminiscent of those seen in stl mutants ( Figure 2B ). Furthermore, fli1-driven expression of atx in ECs was sufficient to phenocopy the excessive angiogenesis displayed by stl mutants (Figure 2F through 2H) , indicating that EC autonomous activation of Autotaxin is sufficient to elicit a proangiogenic response. Finally, downregulation of atx using atx MOs at doses that did not elicit any noticeable vascular defects in WT siblings, was sufficient to rescue the excessive angiogenesis phenotype of stl mutants ( Figure 2I through 2L), confirming that Autotaxin acts downstream of ApoB lipoproteins in ECs. A similar effect was observed after treatment with the specific ATX chemical inhibitor HA-130 27, 31 ( Figure 2M through 2P ). Next, we examined whether Autotaxin downregulation accounts for the vascular phenotypes seen in hyperlipidemic apoCII morphants ( Figure 3A and 3B ). Although injection of control MO did not induce any morphological ( Figure 3A and 3E) or gene expression ( Figure III in the online-only Data Supplement) changes, atx MO injection resulted in early vascular defects ( Figure 3C and 3E ), 29 similar to those observed in apoCII morphants ( Figure 3B and 3F) . Accordingly, EC-specific overexpression of atx, driven by the fli1 promoter, was sufficient to rescue the impaired vasculature of apoCII morphants ( Figure 3D and 3F) . Altogether, these results highlight Autotaxin as a key player in the molecular cascade underlying the response of ECs to plasma lipoproteins.
The detected changes in EC expression of atx could be secondary to global effects of lipoprotein starvation versus overload. Alternatively, they could reflect a direct EC autonomous response to contrasting lipoprotein levels. To distinguish between these 2 possibilities, we turned to cultured human umbilical vein endothelial cells (HUVECs) and assessed the impact of LDL and VLDL on AUTOTAXIN expression and function (Figure 4 ). Addition of LDL to HUVEC culture medium resulted in reduced levels of both ATX mRNA ( Figure 4A ), and secreted AUTOTAXIN protein ( Figure 4B) , indicating a direct effect of LDL on AUTOTAXIN production by ECs. To further investigate the functional link between ApoB lipoproteins and AUTOTAXIN, we evaluated the ability of HUVECs to form tubes after exposure to LDL, VLDL, and LDL+AUTOTAXIN. As shown in Figure 4C through 4F, LDL supply resulted in significant reduction in the average number of tubes, total tube length, and total tube area. In line with the key role of AUTOTAXIN in mediating lipoprotein effects on ECs, addition of AUTOTAXIN to the LDL-containing medium was sufficient to significantly restore tube formation in HUVECs ( Figure 4C through 4F) . Similar results were obtained when VLDL was added to the HUVEC medium ( Figure 4G through 4I ). Finally, we assessed the ability of HUVECs exposed to different treatments to migrate toward VEGF in a transwell migration assay ( Figure 4J ). Also in this case, LDL addition to the medium significantly decreased EC migration toward a VEGF gradient, whereas AUTOTAXIN supply restored it.
Taken together, our results suggest that ApoB lipoproteins directly regulate EC behavior and highlight Autotaxin as a major player in this cascade.
Autotaxin is known to act as the major extracellular enzyme generating the bioactive, lipid-signaling molecule LPA through lysophosphatidylcholine hydrolysis. 32 To ascertain whether autotaxin function in ECs in response to lipoproteins involves LPA activity, we first investigated whether differential atx expression in zebrafish embryos results in concomitant changes of LPA levels. For that purpose, we extracted the entire lipid fraction from 3 dpf stl mutants and atx morphants using one-step methanol extraction 33 and submitted it to liquid chromatography-mass spectrometry analyses ( Figure 5A ). Downregulation of autotaxin using atx MO resulted in Conversely, we detected increased levels of LPA in stl mutants, which feature enhanced atx expression, indicating a direct correlation between Autotaxin levels and LPA production in vivo.
We next asked whether LPA itself contributes to the vascular phenotypes observed in these embryos. Although LPA was shown to promote proliferation and migration of ECs in culture, 20,23 evidence for its direct proangiogenic function in vivo are scarce. 34, 35 LPA supply to zebrafish embryos resulted in a dose-dependent proangiogenic response, both when added to the embryo water ( Figure 5B through 5D ) and after intravascular injection, which mimics its physiological presentation ( Figure 5E through 5G) . In contrast, oleic acid supply did not induce ectopic sprouting ( Figure 5H through 5J) , confirming the specificity of LPA in eliciting a proangiogenic response.
The effects of LPA are known to be exerted through the binding and activation of specific LPA receptors belonging to the superfamily of G-protein-coupled receptors. 22, 36 Previous reports have demonstrated that LPA receptors play an important role in zebrafish vascular development as well. 29 We thus decided to investigate whether LPA receptors play a role in conveying the lipoprotein-autotaxin-LPA signaling in ECs. To this end, we first searched for LPA receptors specifically expressed in ECs. qRT-PCR on FACS-sorted fli:EGFP + ECs showed that lpar1 and lpar5a expression is highly enriched in ECs, as compared with other LPA receptors ( Figure 6A ). In situ hybridization for lpar1 and lpar5a at 24 hpf confirmed the vascular expression of both receptors ( Figure 6B ). Interestingly, lpar1 and lpar5a were the only LPA receptors that showed significant changes in the microarray data. Specifically, their expression was decreased in apoCII morphant-derived ECs, as confirmed by qRT-PCR (Figure IVA and IVB and Table VI in the online-only Data Supplement). These results suggest that elevated lipoprotein levels result not only in decreased transcription of atx with concomitant reduction of LPA levels but also in reduced ability to transduce the Autotaxin-LPA axis signal because of downregulation of LPA receptor expression in ECs. Finally, we reasoned that if Autotaxin exerts its proangiogenic effects in stl mutants through LPA activity, inhibition of LPA receptors should result in reduced ectopic angiogenesis. As seen in Figure 6C through 6E, treatment of stl embryos with the LPA-R(1-3) chemical inhibitor ki16425, previously shown to efficiently inhibit LPA receptors 1 to 3 in zebrafish, 29 induced a reduction in both the number and length of stl ectopic sprouts, indicating a significant role for the LPA/LPA-R axis in the Autotaxin-mediated response of ECs to ApoB lipoproteins. 
Discussion
In this work, we provide the first in vivo gene expression profiling of ECs facing different levels of plasma lipoproteins. We show that lipoproteins regulate the expression of the secreted enzyme Autotaxin, which in turn affects EC proliferation and migration. Lipoprotein-dependent atx downregulation resulted in impaired angiogenesis, whereas increased atx expression caused excessive vessel sprouting in zebrafish embryos. Moreover, addition of ATX to the medium of cultured HUVECs was sufficient to rescue the inhibitory effects of LDL in both tube formation and migration assays. Finally, we show that in vivo, the proangiogenic effects of Autotaxin are exerted through the generation of the bioactive, lipid-signaling molecule LPA and that LPA receptors are involved as well in the induction of ectopic sprouting in response to lipoprotein deficiency ( Figure 6F) .
Interestingly, our microarray analysis revealed only 23 genes whose expression in ECs changed in opposite directions in response to lipoprotein depletion versus overload. Among them, enpp2/autotaxin (atx) was upregulated under low lipoprotein levels and downregulated in hyperlipidemia. Recently, ATX levels were shown to be reduced in subcutaneous fat and serum of obese human patients. 37 This inverse correlation between ATX and lipoprotein levels, which is in line with our observations in hyperlipidemic zebrafish embryos, highlights a potential conservation of this mechanism from embryonic development to pathological conditions in adult life.
One of the major questions concerning Autotaxin function in vivo relates to the nature of the cells that secrete it to the plasma. Both high endothelial venules 38 and adipocytes 39, 40 were suggested as possible sources in vivo, whereas in vitro AUTOTAXIN was found to be expressed and secreted by adipocytes 40 and HUVECs. 41 Here, we identify enriched expression of atx mRNA in ECs of zebrafish embryos. Notably, our analyses were conducted at 3 dpf, a stage at which adipocytes are not yet formed, [42] [43] [44] highlighting the endothelium as an important source for Autotaxin during embryonic development. Furthermore, this makes the early zebrafish embryo an attractive model for studying the specific contribution of ECs to plasma Autotaxin. and length (E) of ectopic SIV sprouts in stl embryos treated with ki16425. N=3, n stl =42, n stl+ki16425 =53. *P number =0.0002, *P length =0.001. F, Low apoprotein B (ApoB) lipoprotein levels result in upregulation of atx expression in ECs, leading to increased LPA production and signaling through specific LPA receptors and to enhanced angiogenesis. In contrast, high lipoprotein levels lead to reduced atx expression in ECs, decreased LPA signaling, and impaired angiogenesis. Scale bar=50 µm.
To date, the bulk activity of Autotaxin has been attributed mostly to its ability to hydrolyze lysophosphatidylcholine to LPA. 32, 45 The importance of Autotaxin's catalytic activity to generate LPA is highlighted by the fact that a single mutation in its active site results in embryonic lethality. 46 Autotaxin was also shown to hydrolyze sphingosylphosphorylcholine to produce sphingosine-1-phosphate, 47 an important regulator of angiogenesis that inhibits VEGF signaling and vascular sprouting. 48, 49 However, Autotaxin's ability to generate sphingosine-1-phosphate in vivo has not been demonstrated to date. 23 Moreover, sphingosine-1-phosphate levels in plasma and serum of Autotaxin heterozygous mice are unaffected, as opposed to LPA levels that are reduced by ≈50%. 25 Although LPA was shown to act as a potent proangiogenic factor in culture, 23 little evidence support this role in vivo. Here, we show that manipulation of Autotaxin expression in zebrafish embryos results in concordant changes in LPA levels and that LPA administration is sufficient to induce ectopic vessel sprouting in these animals, strongly supporting a proangiogenic role for LPA in vivo. LPA has been shown to bind several receptors and elicit different receptor-dependent and cell type-dependent responses. 50 Nonetheless, deletion of individual LPA receptors has not been associated with embryonic vascular defects. Moreover, the vascular phenotype observed in Autotaxin knockout mice is significantly more severe than the one caused by deletion of LPA receptors 1 to 4 or in different double knockout combinations. [51] [52] [53] Similarly, in zebrafish embryos, combined downregulation of LPA receptors, resulted in vascular defects that were not detected following ablation of the individual genes. 29 The difference between the resulting Autotaxin and LPA receptor knockout phenotypes could be attributed to a combinatorial pattern of expression of the receptors, which leaves room for redundancy and for tissue-specific functions. In our work, we find that lpar1 and lpar5a are expressed by ECs and are significantly downregulated in apoCII morphants, suggesting that LPA signaling is further decreased in the ECs of these embryos. We also show that inhibiting LPA receptors 1 to 3 can partially rescue the excessive angiogenesis phenotype in stl mutants, thereby linking LPA receptor activity to EC behavior in vivo.
Altogether, our results show that lipoprotein deficiency leads to increased Autotaxin expression in ECs, whereas lipoprotein overload induces its downregulation. Autotaxin then modulates angiogenesis through generation of its main product LPA, which exerts its function through the activation of LPA receptors in ECs. The identification of lipoproteindependent regulation of the Autotaxin-LPA axis within ECs sheds light on the interactions between lipoproteins and the endothelium during embryonic development and provides new insights into lipoprotein-related vascular pathologies. Future research using the zebrafish model will likely unearth additional components of this signaling cascade both during embryonic development and in lipoprotein-related pathological angiogenesis.
